Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: High rate of mild cellular rejection

Transplantation

Volumn 89, Issue 6, 2010, Pages 702-706

  Oettl, Tobias ^a   Zuliani, Eugenia ^b   Gaspert, Ariana ^b   Hopfer, Helmut ^c   Dickenmann, Michael ^a   Fehr, Thomas ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

ABO incompatible kidney transplantation; Immunoadsorption; Steroid withdrawal

Indexed keywords

BASILIXIMAB; CREATININE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DISEASE; HISTOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SINGLE DRUG DOSE;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; BLOOD GROUPING AND CROSSMATCHING; CREATININE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDNISONE; RISK ASSESSMENT; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949900894     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c9cc67     Document Type: Article

References (17)

1. Alexandre GPJ, Squifflet JP, de Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
2. Tyden G, Donauer J, Wadström J, et al. Implementation of a protocol for ABO incompatible kidney transplantation\A three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.
3. KatoY, TojimbaraT, IwadohK, et al. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Int Immunopharmacol 2006; 6: 1984.
4. Oettl T, Halter J, Bachmann A, et al. ABO blood group-incompatible living donor kidney transplantation: A prospective, single-centre analysis including serial protocol biospies. Nephrol Dial Transplant 2009; 24: 298.
5. Matas AJ. Minimization of steroids in kidney transplantation. Transpl Int 2009; 22: 38.
6. Rajab A, Pelletier RP, Henry ML, et al. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant 2006; 20: 537.
7. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. Am J Soc Nephrol 1996; 7: 158.
8. Galliford J, Charif R, Chan KK, et al. ABO incompatible living renal transplantation with a steroid sparing protocol. Transplantation 2008; 7: 901.
9. Tyden G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantation without splenectomy, using antigen-specific immuno-adsorption and rituximab. Am J Transplant 2005; 5: 145.
10. Haas M, Segev DL, Racusen LC, et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allo-grafts. J Am Soc Nephrol 2009; 20: 197.
11. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 4: 753.
12. Miozzari M, Ambühl PM. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: Adrenal response and clinical implications. Nephrol Dial Transplant 2004; 19: 2615.
13. Valli P, Puga Yung G, Fehr T, et al. Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transplant 2009; 9: 1072.
14. Jaber JJ, Feustel PJ, Elbhloul O, et al. Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clin Transplant 2007; 21: 101.
15. Opelz G, Döhler B, Laux G; for the Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005; 5: 720.
16. Woodle ES, Astellas steroid withdrawal study group. A randomized double blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: Three-year results. Am J Transplant 2006; 6: S177.
17. Montagnino G, Sandrini S, Iorio B, et al. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Nephrol Dial Transplant 2008; 23: 707.